Urge the government to keep MS medications on the PBS
The issue
I was diagnosed with Multiple Sclerosis (MS) at the young age of 23. Despite the challenges of this life-altering condition, I have diligently worked to maintain a normal and active life. However, my last two relapses were frightening and threatened to significantly impact my independence. That's when a lifeline was extended to me in the form of the medication Ocrevus, a treatment that can prevent future relapses. I am not speaking out just for myself, but also as a mother and for my family, who now must contend with the devastating reality of this autoimmune disease.
In Australia, the Pharmaceutical Benefits Scheme (PBS) plays a crucial role in ensuring that essential medications are affordable and accessible to those who need them the most. Removing MS medications like Ocrevus from the PBS would place an enormous financial burden on individuals living with this condition and their families, pushing many to the brink of despair. A single infusion of Ocrevus without subsidy can cost tens of thousands of dollars, a sum that is simply unattainable for most.
Multiple Sclerosis affects more than 25,000 Australians, and the number is steadily growing each year. This disease does not discriminate; it strikes young people in the prime of their lives, threatening their future and tearing families apart. The availability of effective medications is essential not only for managing symptoms but for preventing further disability and preserving quality of life.
By keeping MS medications on the PBS, the government can demonstrate its commitment to supporting people with disabilities and chronic illnesses. This is not merely a financial issue; it is about upholding a standard of care that every Australian deserves. Ensuring continued access to these life-changing medications is an investment in the health, well-being, and dignity of thousands of Australians.
I urge the Government to prioritize the needs of the MS community and keep these life-changing medications on the Pharmaceutical Benefits Scheme. Please join me in calling on our leaders to preserve accessibility and affordability of MS treatments. Sign this petition today and support our fight for life-saving access.
96
The issue
I was diagnosed with Multiple Sclerosis (MS) at the young age of 23. Despite the challenges of this life-altering condition, I have diligently worked to maintain a normal and active life. However, my last two relapses were frightening and threatened to significantly impact my independence. That's when a lifeline was extended to me in the form of the medication Ocrevus, a treatment that can prevent future relapses. I am not speaking out just for myself, but also as a mother and for my family, who now must contend with the devastating reality of this autoimmune disease.
In Australia, the Pharmaceutical Benefits Scheme (PBS) plays a crucial role in ensuring that essential medications are affordable and accessible to those who need them the most. Removing MS medications like Ocrevus from the PBS would place an enormous financial burden on individuals living with this condition and their families, pushing many to the brink of despair. A single infusion of Ocrevus without subsidy can cost tens of thousands of dollars, a sum that is simply unattainable for most.
Multiple Sclerosis affects more than 25,000 Australians, and the number is steadily growing each year. This disease does not discriminate; it strikes young people in the prime of their lives, threatening their future and tearing families apart. The availability of effective medications is essential not only for managing symptoms but for preventing further disability and preserving quality of life.
By keeping MS medications on the PBS, the government can demonstrate its commitment to supporting people with disabilities and chronic illnesses. This is not merely a financial issue; it is about upholding a standard of care that every Australian deserves. Ensuring continued access to these life-changing medications is an investment in the health, well-being, and dignity of thousands of Australians.
I urge the Government to prioritize the needs of the MS community and keep these life-changing medications on the Pharmaceutical Benefits Scheme. Please join me in calling on our leaders to preserve accessibility and affordability of MS treatments. Sign this petition today and support our fight for life-saving access.
Supporter voices
Petition Updates
Share this petition
Petition created on 11 July 2026